Showing results (91-100 of 13,430) with videos related to

Sort By:
Pageof 1,343
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Pitfalls in reimbursement decisions for oncology drugs in South Korea: need for addressing the ethical dimensions in technology assessmentEun Cho, Eun-Cheol Park, Myoung Sheen Kang
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Sociodemographic predictors of recall and recognition of colorectal cancer symptoms and anticipated delay in help- seeking in a multiethnic Asian populationKwong Weng Loh, Hazreen Abdul Majid, Maznah Dahlui, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Association of XRCC1 gene polymorphisms with breast cancer susceptibility in Saudi patientsFatima Masoud Al Mutairi, Mohammed Alanazi, Manal Shalaby, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Surgical treatment for early esophageal squamous cell carcinomaShao-Bin Chen, Hong-Rui Weng, Geng Wang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Potential therapeutic efficacy of curcumin in liver cancerXin-Zheng Dai, Hai-Tao Yin, Ling-Fei Sun, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer casesXue Dou, Ren-Ben Wang, Hong-Jiang Yan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Prognostic significance of α5β1-integrin expression in cervical cancerHua-Yi Wang, Zhe Chen, Zhu-Hui Wang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Prognostic value of T cell immunoglobulin mucin-3 in prostate cancerYong-Rui Piao, Long-Zhen Piao, Lian-Hua Zhu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Impact of postoperative chemoradiotherapy and chemoradiotherapy alone for esophageal cancer in North-West IranSeyed Kazem Mirinezhad, Mohammad Hossein Somi, Masoud Shirmohamadi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 27, 2013
Phase II clinical study on the GEMOX regimen as second- line therapy for advanced ovarian cancerShao-Fei Yuan, Lian-Ping Zhang, Lin-Jia Zhu, et al.
Pageof 1,343